Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing Transrectal Ultrasound (TRUS)-Guided Prostate Biopsy for Real-Time Tissue Evaluation

NCT03504761 is registered in ClinicalTrials.gov with Precision Biopsy, Inc. as lead sponsor.

NCT NCT03504761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03504761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing Transrectal Ultrasound (TRUS)-Guided Prostate Biopsy for Real-Time Tissue Evaluation
Lead sponsor
Precision Biopsy, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 25, 2018
Completion date
December 31, 2020
Enrollment
325 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cellular diagnosis, prostate cancer